mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.7 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.7 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
0.11 |
0.7 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |